心肌肌钙蛋白I联合超敏C-反应蛋白检测诊断急性

目的：探讨心肌肌钙蛋白I（cTnI）联合超敏C-反应蛋白（hs—CRP）检测诊断急性心梗死（AMI）的临床应用价值。方法：选取2009年2月-2012年12月笔者所在医院确诊的AMI患者134例（AMI组），同期健康体检正常成人120例（对照组），比较两组cTnl、hs—CRP水平。结果：AMI组发作不同时段的cTnl、hs—CRP检出率均显著高于对照组（P〈0．01）。其中，cTnl检出率在发作12～24h检出率达到峰值（100％）；hs—CRP在发作8～12h检出率达到峰值（100％）。AMI的cTnl、hs—CRP诊断特异度分别为98．51％、87．31％。结论：血清cTnl联合hs—CRP检测可作为AMI早期诊断和预测的一个敏感、特异指标。

cTnI Joint hs - CRP Detection and Diagnosis of AMI Application and Clinical Researc

Objective： To investigate cTnI joint hs-CRP detection and diagnosis of AMI clinical application value.Method ： 134 AMI patients from 2009 February to 2012 year in December in our hospital diagnosed cases （ AMI group ）, 120 cases of normal adult healthy （ control group ）, compared two groups of cTnI, hs-CRP level.Result： Group AMI attack in different periods, the detection rate of hs-CRP in cTnI were significantly higher than those of control group （ P〈0.01 ）.Among them, the detection rate of cTnI in attack detection rate of 12-24 h reached peak （ 100% ）; hs-CRP peak in the attack of 8-12 h（100%） .The specificityofAMIcTnI, hs-CRP diagnosis were 98.51%, 87.31%.Conclusion： Serum cTnI joint hs-CRP detection can be used as AMI early diagnosis and prediction of a sensitive and specific indicators.